{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:51:40Z","timestamp":1740153100698,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["21A320070"],"award-info":[{"award-number":["21A320070"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["SBGJ202003050"],"award-info":[{"award-number":["SBGJ202003050"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>IgA nephropathy (IgAN) is a common primary renal disease in childhood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty blood samples and renal tissue from patients with IgAN, 20 blood samples from healthy children and 10 normal renal tissue were collected. Serum Gd-IgA1 and renal Gd-IgA1, CD31, \u03b1-SMA and vimentin were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The serum Gd-IgA1 concentration in the IgAN group was significantly higher. Gd-IgA1 was not expressed in normal kidneys, which was positive in the IgAN group. Gd-IgA1 levels in serum and renal tissue were not related. The expression of CD31 decreased significantly in IgAN group, while the expression of \u03b1-SMA and vimentin increased significantly. There was no significant correlation between the renal concentration of Gd-IgA1 and CD31, \u03b1-SMA and vimentin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The increased Gd-IgA1 in the serum and kidney may promote the pathogenesis of IgAN. The serum Gd-IgA1 cannot predict the extent of its deposition in the kidney. Endothelial mesenchymal transition (EndMT) may be involved in the pathogenesis of renal fibrosis in IgAN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01468-x","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T09:04:13Z","timestamp":1683795853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy"],"prefix":"10.1186","volume":"49","author":[{"given":"Wanyu","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"issue":"4S","key":"1468_CR1","first-page":"1","volume":"100","author":"Kidney Disease","year":"2021","unstructured":"Kidney Disease. Improving global outcomes glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1\u2013S276.","journal-title":"Kidney Int"},{"issue":"1","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the spectrum of kidney Diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10\u20139.","journal-title":"Kidney Dis (Basel)"},{"key":"1468_CR3","doi-asserted-by":"crossref","unstructured":"Ohyama Y, Renfrow MB, Novak J, Takahashi K. Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don\u2019t Know. J Clin Med. 2021;10(16).","DOI":"10.3390\/jcm10163467"},{"issue":"6","key":"1468_CR4","first-page":"1668","volume":"119","author":"H Suzuki","year":"2009","unstructured":"Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119(6):1668\u201377.","journal-title":"J Clin Invest"},{"key":"1468_CR5","doi-asserted-by":"publisher","first-page":"7806438","DOI":"10.1155\/2016\/7806438","volume":"2016","author":"H Suzuki","year":"2016","unstructured":"Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, et al. Galactose-deficient IgA1 as a candidate urinary polypeptide marker of IgA Nephropathy? Dis Markers. 2016;2016:7806438.","journal-title":"Dis Markers"},{"key":"1468_CR6","doi-asserted-by":"crossref","unstructured":"Knoppova B, Reily C, King RG, Julian BA, Novak J, Green TJ. Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment. J Clin Med. 2021;10(19).","DOI":"10.3390\/jcm10194501"},{"issue":"5","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-021-00883-8","volume":"43","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Novak J. IgA glycosylation and immune complex formation in IgAN. Semin Immunopathol. 2021;43(5):669\u201378.","journal-title":"Semin Immunopathol"},{"key":"1468_CR8","doi-asserted-by":"publisher","first-page":"tkac011","DOI":"10.1093\/burnst\/tkac011","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu L, Sun Q, Davis F, Mao J, Zhao H, Ma D. Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies. Burns Trauma. 2022;10:tkac011.","journal-title":"Burns Trauma"},{"key":"1468_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-319-51436-9_13","volume":"60","author":"AS Cruz-Solbes","year":"2017","unstructured":"Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ. 2017;60:345\u201372.","journal-title":"Results Probl Cell Differ"},{"key":"1468_CR10","doi-asserted-by":"crossref","unstructured":"Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration. Int J Mol Sci. 2020;21(12).","DOI":"10.3390\/ijms21124271"},{"issue":"7","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ejcb.2018.07.005","volume":"97","author":"L Hong","year":"2018","unstructured":"Hong L, Du X, Li W, Mao Y, Sun L, Li X. EndMT: a promising and controversial field. Eur J Cell Biol. 2018;97(7):493\u2013500.","journal-title":"Eur J Cell Biol"},{"issue":"2","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in physiology and in the Pathogenesis of Human Diseases. Physiol Rev. 2019;99(2):1281\u2013324.","journal-title":"Physiol Rev"},{"issue":"12","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008;19(12):2282\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2353\/ajpath.2009.090096","volume":"175","author":"J Li","year":"2009","unstructured":"Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol. 2009;175(4):1380\u20138.","journal-title":"Am J Pathol"},{"issue":"12","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.111.259960","volume":"110","author":"A von Gise","year":"2012","unstructured":"von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110(12):1628\u201345.","journal-title":"Circ Res"},{"issue":"9","key":"1468_CR16","first-page":"643","volume":"55","author":"Nephrology section CPS, Chinese Medical Association","year":"2017","unstructured":"Nephrology section CPS, Chinese Medical Association. Evidence-based guidelines for diagnosis and treatment of primary IgA nephropathy (2016). \u4e2d\u534e\u513f\u79d1\u6742\u5fd7. 2017;55(9):643\u20136.","journal-title":"\u4e2d\u534e\u513f\u79d1\u6742\u5fd7"},{"issue":"8","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ndt\/gfv221","volume":"30","author":"J Yasutake","year":"2015","unstructured":"Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30(8):1315\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1468_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5114\/ceji.2018.77386","volume":"43","author":"M Mizerska-Wasiak","year":"2018","unstructured":"Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Maldyk J, Dziedzic-Jankowska K, Leszczynska B, et al. Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schonlein nephritis. Cent Eur J Immunol. 2018;43(2):162\u20137.","journal-title":"Cent Eur J Immunol"},{"issue":"3","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","volume":"93","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700\u20135.","journal-title":"Kidney Int"},{"issue":"10","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2215\/CJN.13711118","volume":"14","author":"P Chen","year":"2019","unstructured":"Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, et al. Plasma galactose-deficient IgA1 and C3 and CKD progression in IgA Nephropathy. Clin J Am Soc Nephrol. 2019;14(10):1458\u201365.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1468_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fphar.2017.00473","volume":"8","author":"Z Ma","year":"2017","unstructured":"Ma Z, Zhu L, Liu Y, Wang Z, Yang Y, Chen L, et al. Lovastatin alleviates endothelial-to-mesenchymal transition in Glomeruli via suppression of oxidative stress and TGF-beta1 signaling. Front Pharmacol. 2017;8:473.","journal-title":"Front Pharmacol"},{"key":"1468_CR22","doi-asserted-by":"publisher","first-page":"20304","DOI":"10.1038\/srep20304","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, et al. ROCK1 induces endothelial-to-mesenchymal transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep. 2016;6:20304.","journal-title":"Sci Rep"},{"issue":"5","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1159\/000493380","volume":"43","author":"F Liu","year":"2018","unstructured":"Liu F, Zhang S, Xu R, Gao S, Yin J. Melatonin attenuates endothelial-to-mesenchymal transition of glomerular endothelial cells via regulating miR-497\/ROCK in Diabetic Nephropathy. Kidney Blood Press Res. 2018;43(5):1425\u201336.","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.arcmed.2010.05.003","volume":"41","author":"C Wang","year":"2010","unstructured":"Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, et al. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation. Arch Med Res. 2010;41(4):255\u201360.","journal-title":"Arch Med Res"},{"issue":"8","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"e73425","DOI":"10.1371\/journal.pone.0073425","volume":"8","author":"L Zhu","year":"2013","unstructured":"Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H. Synergistic effect of mesangial cell-induced CXCL1 and TGF-beta1 in promoting podocyte loss in IgA nephropathy. PLoS ONE. 2013;8(8):e73425.","journal-title":"PLoS ONE"},{"key":"1468_CR26","doi-asserted-by":"crossref","unstructured":"Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P. TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci. 2017;18(10).","DOI":"10.3390\/ijms18102157"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01468-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T09:22:22Z","timestamp":1683796942000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01468-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01468-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2021-KY-1221-002). Informed consent forms were obtained from the parents of the patients. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}